Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial–mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKT

Endometrial cancer is the most common gynecological cancer in the developed countries. Type II transmembrane serine proteases 4 (TMPRSS4) is a newly discovered transmembrane protein, which may be related to the invasion, metastasis of the tumor and the poor prognosis. This study aims to investigate...

Full description

Bibliographic Details
Main Authors: Huan Xiao, Zhian Zhang, Dan Peng, Chunqing Wei, Benling Ma
Format: Article
Language:English
Published: Taylor & Francis Group 2021-07-01
Series:Animal Cells and Systems
Subjects:
Online Access:http://dx.doi.org/10.1080/19768354.2021.1944311
_version_ 1818724287142428672
author Huan Xiao
Zhian Zhang
Dan Peng
Chunqing Wei
Benling Ma
author_facet Huan Xiao
Zhian Zhang
Dan Peng
Chunqing Wei
Benling Ma
author_sort Huan Xiao
collection DOAJ
description Endometrial cancer is the most common gynecological cancer in the developed countries. Type II transmembrane serine proteases 4 (TMPRSS4) is a newly discovered transmembrane protein, which may be related to the invasion, metastasis of the tumor and the poor prognosis. This study aims to investigate the role of TMPRSS4 in endometrial cancer and the detailed molecular mechanism. The results showed that TMPRSS4 was highly expressed in human endometrial cancer cells (HEC1A and Ishikawa). TMPRSS4 knockdown inhibited proliferation of endometrial cancer cells. In TMPRSS4 knockdown cells, the invasion of cells was significantly supressed. The expression of E-cadherin was significantly enhanced, while the levels of fibronectin and vimentin decreased in TMPRSS4 knockdown cells, which indicated thatTMPRSS4 knockdown attenuated the EMT of cancer cells. TMPRSS4 positively regulated the activation of MAPK and AKT signaling pathways in endometrial cancer. In conclusion, this study indicated that TMPRSS4 may be associated with the progression of endometrial cancer through promoting proliferation, invasion and EMT via activation of MAPK and AKT in endometrial cancer cells. TMPRSS4 may be a new and more effective target or therapeutic strategy for treating endometrial cancer.
first_indexed 2024-12-17T21:24:01Z
format Article
id doaj.art-b900361588ff480a90c832db552d34f4
institution Directory Open Access Journal
issn 1976-8354
2151-2485
language English
last_indexed 2024-12-17T21:24:01Z
publishDate 2021-07-01
publisher Taylor & Francis Group
record_format Article
series Animal Cells and Systems
spelling doaj.art-b900361588ff480a90c832db552d34f42022-12-21T21:32:04ZengTaylor & Francis GroupAnimal Cells and Systems1976-83542151-24852021-07-0125421121810.1080/19768354.2021.19443111944311Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial–mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKTHuan Xiao0Zhian Zhang1Dan Peng2Chunqing Wei3Benling Ma4Huanggang Central Hospital Affiliated to Changjiang UniversityHuanggang Central Hospital Affiliated to Changjiang UniversityHuanggang Central Hospital Affiliated to Changjiang UniversityHuanggang Central Hospital Affiliated to Changjiang UniversityThe Second Affiliated Hospital of Hunan University of Chinese MedicineEndometrial cancer is the most common gynecological cancer in the developed countries. Type II transmembrane serine proteases 4 (TMPRSS4) is a newly discovered transmembrane protein, which may be related to the invasion, metastasis of the tumor and the poor prognosis. This study aims to investigate the role of TMPRSS4 in endometrial cancer and the detailed molecular mechanism. The results showed that TMPRSS4 was highly expressed in human endometrial cancer cells (HEC1A and Ishikawa). TMPRSS4 knockdown inhibited proliferation of endometrial cancer cells. In TMPRSS4 knockdown cells, the invasion of cells was significantly supressed. The expression of E-cadherin was significantly enhanced, while the levels of fibronectin and vimentin decreased in TMPRSS4 knockdown cells, which indicated thatTMPRSS4 knockdown attenuated the EMT of cancer cells. TMPRSS4 positively regulated the activation of MAPK and AKT signaling pathways in endometrial cancer. In conclusion, this study indicated that TMPRSS4 may be associated with the progression of endometrial cancer through promoting proliferation, invasion and EMT via activation of MAPK and AKT in endometrial cancer cells. TMPRSS4 may be a new and more effective target or therapeutic strategy for treating endometrial cancer.http://dx.doi.org/10.1080/19768354.2021.1944311type ii transmembrane serine proteases 4 (tmprss4)endometrial cancerepithelial–mesenchymal transitionmapkakt
spellingShingle Huan Xiao
Zhian Zhang
Dan Peng
Chunqing Wei
Benling Ma
Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial–mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKT
Animal Cells and Systems
type ii transmembrane serine proteases 4 (tmprss4)
endometrial cancer
epithelial–mesenchymal transition
mapk
akt
title Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial–mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKT
title_full Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial–mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKT
title_fullStr Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial–mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKT
title_full_unstemmed Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial–mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKT
title_short Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial–mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKT
title_sort type ii transmembrane serine proteases 4 tmprss4 promotes proliferation invasion and epithelial mesenchymal transition in endometrial carcinoma cells hec1a and ishikawa via activation of mapk and akt
topic type ii transmembrane serine proteases 4 (tmprss4)
endometrial cancer
epithelial–mesenchymal transition
mapk
akt
url http://dx.doi.org/10.1080/19768354.2021.1944311
work_keys_str_mv AT huanxiao typeiitransmembraneserineproteases4tmprss4promotesproliferationinvasionandepithelialmesenchymaltransitioninendometrialcarcinomacellshec1aandishikawaviaactivationofmapkandakt
AT zhianzhang typeiitransmembraneserineproteases4tmprss4promotesproliferationinvasionandepithelialmesenchymaltransitioninendometrialcarcinomacellshec1aandishikawaviaactivationofmapkandakt
AT danpeng typeiitransmembraneserineproteases4tmprss4promotesproliferationinvasionandepithelialmesenchymaltransitioninendometrialcarcinomacellshec1aandishikawaviaactivationofmapkandakt
AT chunqingwei typeiitransmembraneserineproteases4tmprss4promotesproliferationinvasionandepithelialmesenchymaltransitioninendometrialcarcinomacellshec1aandishikawaviaactivationofmapkandakt
AT benlingma typeiitransmembraneserineproteases4tmprss4promotesproliferationinvasionandepithelialmesenchymaltransitioninendometrialcarcinomacellshec1aandishikawaviaactivationofmapkandakt